Zacks Investment Management’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-38,473
Closed -$320K 516
2020
Q2
$320K Buy
+38,473
New +$320K 0.01% 436